Lingeba

Lingeba is a China-based biotechnology company specializing in high-throughput single-cell analysis and functional screening for drug discovery. The company's core technology, the LingCell platform, integrates microfluidics and single-cell sequencing to rapidly identify high-affinity antibodies and T-cell receptors (TCRs). By streamlining the transition from single-cell functional validation to sequence recovery, Lingeba accelerates the development of biologics and cell therapies. The firm focuses on therapeutic areas including oncology, immunology, and infectious diseases through both internal programs and strategic partnerships with pharmaceutical companies.